Nexalin Says Post Hoc ADAS-Cog Analysis Of Gen-2 SYNC Alzheimer's Trial Found 10 Of 20 Evaluable Active-Arm Patients Improved 4 Or More Points; Findings To Inform Planned U.S. Pilot Study